Egfr-positive Solid Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-01-18
Clinical Trial Update: A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A study of MRG003 in EGFR-positive advanced or metastatic solid tumors is ongoing in Phase 1/2; current status is unknown.